AnovoRx was founded in 2012 by a group of specialty pharmacy and biotech pharmaceutical veterans. Our founders believe that despite much of the recent consolidation of specialty pharmacies, there is still a tremendous marketplace need for personalized, high-touch specialty pharmacy services where patients, physicians and their staff get to deal directly with pharmacists and customer care staff who are dedicated to and specialize in their needed medications and related diseases.
AnovoRx is focused on being the patients’, physicians’ and pharmaceutical companies’ premier source for customized treatment and support programs that address the unique needs of patients with certain complex, costly and chronic diseases.
AnovoRx’s management team and employees have significant experience in the specialty pharmacy and biotechnology drug industries. They bring outstanding operational and financial expertise along with unparalleled knowledge of the unique needs and best-practice solutions for patients, physicians, hospitals, payers and pharmaceutical manufacturers.
AnovoRx is located in Memphis, Tennessee and is licensed to distribute prescription pharmaceuticals across the United States. The approximate 25,000 square foot corporate facility in Memphis includes the company’s national retail and wholesale distribution centers and the company’s corporate offices.
Founder, President and Chief Executive Officer
AnovoRx Group, LLC
Mr. Peters has been President and Chief Executive Officer of AnovoRx since its inception in 2012. He was the Senior Vice President of Reimbursement and Technology for Accredo Health, Inc. from 2003 through 2005, when the company was acquired by Medco Health Solutions, Inc. Mr. Peters then served in various executive positions with Medco and Accredo until 2010, including Chief Operating Officer and Chief Financial Officer of Accredo. Mr. Peters joined Accredo in 2003 as Vice President of Process Engineering & Business Integration after working with Accredo as an independent consultant for a year. Prior to joining Accredo, Mr. Peters was the Chief Financial Officer and a Partner of Paradigm Capital Partners, a venture capital firm, from 2000 to 2002. From 1988 through 2000, he was employed by international accounting and consulting firm Ernst & Young LLP.
Mr. Stevens has been in an investor and advisor in private equity based companies since 2006. Mr. Stevens was employed in various executive capacities at Le Bonheur Health Systems, Inc. (LHS), from 1979 to 1996. In May 1996, Mr. Stevens led a management buyout of Accredo Health, Inc., a subsidiary of LHS where he served as CEO, a leading provider of specialty pharmacy services to patients, payers and pharmaceutical manufacturers. Accredo became a publicly-traded company in April of 1999. Mr. Stevens served as Chief Executive Officer of Accredo until acquisition of Accredo by Medco Health Solutions, Inc. in 2005. In 2006, he was elected to the Medco Health Solutions Board of Directors, on which he served until the sale of Medco to Express Scripts, Inc. in 2012. Mr. Stevens is also on the Board of Directors of Wright Medical Group, Inc.; Viasystems, Inc.; and Allscripts, Inc., all publicly traded companies, and serves as a director of various non-profit charitable organizations including the University of Tennessee Research Foundation.
Mr. Kimbrough is an owner of The Barnett Group, a Memphis-based provider of employee benefit and financial services. Mr. Kimbrough served as Senior Vice President, Chief Financial Officer and Treasurer of Accredo Health, Inc. from 1990 to 2005 when Accredo was acquired by Medco Health Solutions, Inc. Previously, Mr. Kimbrough, a certified public accountant, was employed by international accounting and consulting firm Ernst & Young LLP from 1980 to 1989. While Chief Financial Officer of publicly-traded Accredo, he received the Institutional Investor Magazine Award for “The Best CFO” for health care and technology in 2005.
Mr. Kimbrough serves on the Board of Directors of Veritas Collaborative LLC, Le Bonheur Children’s Medical Center and The Make-A-Wish Foundation of the Mid-South, for which he serves as Vice Chairman. He previously served as Chairman of the Board of TrustOne Bank until its acquisition in 2013, and served on the boards of Aldagen Inc.; Pediatric Services of America; and Bostwick Laboratories.
Mr. Callahan has been a private equity investor and advisor since he retired from Accredo Health, Inc. in 2007. He was a Senior Vice President of Accredo from 1997 through 2007, where he also served as President of Hemophilia Health Services, Inc. (HHS), an Accredo subsidiary focused nationally on bleeding disorders and hemophilia therapy management.
Mr. Hanover is a co-founder of publicly held GTx, Inc., — a biopharmaceutical company dedicated to the discovery, development and commercialization of therapeutics primarily related to the treatment of serious men’s health conditions — and has served as its President and Chief Operating Officer since its inception in September 1997. He also currently serves as the GTx, Inc.’s interim Chief Executive Officer and as a member of the GTx Board of Directors.
Prior to joining GTx, Mr. Hanover was a founder of Equity Partners International, Inc., a private equity firm in Memphis, Tennessee, and participated as a founder and investor in three healthcare companies. From 1985 to 1997, Mr. Hanover was a Senior Vice President and a member of the Executive Management Committee of National Bank of Commerce in Memphis, Tennessee. Mr. Hanover holds a B.S. in Biology from the University of Memphis and an MBA in Finance from the University of Memphis.
1710 N Shelby Oaks Drive, Suite 2
Memphis, TN 38134